Oncodesign Precision Medicine S.A
Develops precision therapies & diagnostics for resistant and metastatic cancers.
ALOPM | Euronext Access Plus
Overview
Corporate Details
- ISIN(s):
- FR001400CM63
- LEI:
- 969500ZDX1IY47LDL876
- Country:
- France
- Address:
- 18 RUE JEAN MAZEN, 21000 DIJON
- Website:
- https://www.oncodesign.com/
- Sector:
- Manufacturing
- Industry:
- Manufacture of pharmaceuticals, medicinal chemical and botanical products
Description
Oncodesign Precision Medicine (OPM) is a biopharmaceutical company established in 2022, specializing in precision medicine. The company's mission is to discover and develop innovative therapeutic and diagnostic solutions to combat therapeutic resistance and metastasis in cancer. OPM's patient-centric approach leverages innovative technologies, including artificial intelligence, to identify novel therapeutic targets and advance a pipeline of preclinical candidates. The core focus is on providing effective treatments for patients with resistant and metastatic cancers.
Unlock This Filing & Millions More
You're one step away from the data you need. Create a free account to instantly view this filing and get access to powerful research tools.
Filings
| Date | Filing | Language | Size | Actions | |
|---|---|---|---|---|---|
| 2025-06-11 18:00 |
Post-Annual General Meeting Information
Informations privilégiées / Autres communiqués
|
French | 466.5 KB | ||
| 2025-05-06 18:00 |
Pre-Annual General Meeting Information
Informations privilégiées / Autres communiqués
|
French | 216.8 KB | ||
| 2025-04-17 18:00 |
Capital/Financing Update
Inside Information / Other news releases
|
English | 341.8 KB | ||
| 2025-04-17 18:00 |
Capital/Financing Update
Informations privilégiées / Autres communiqués
|
French | 331.1 KB | ||
| 2025-04-03 18:00 |
Earnings Release
Informations privilégiées / Communiqué sur comptes, résultats
|
French | 364.7 KB | ||
| 2025-04-03 18:00 |
Earnings Release
Inside Information / News release on accounts, results
|
English | 379.5 KB | ||
| 2025-03-24 18:11 |
Legal Proceedings Report
Informations privilégiées / Autres communiqués
|
French | 540.6 KB | ||
| 2025-03-24 18:11 |
Legal Proceedings Report
Inside Information / Other news releases
|
English | 629.3 KB | ||
| 2025-03-04 17:45 |
Board/Management Information
Nomination of Christophe Thurieau as an Independent Member of OPM Board of Dire…
|
French | 293.7 KB | ||
| 2025-03-04 17:45 |
Board/Management Information
Nomination of Christophe Thurieau as an Independent Member of OPM Board of Dire…
|
English | 287.9 KB | ||
| 2025-01-08 18:00 |
Capital/Financing Update
Informations privilégiées / Autres communiqués
|
French | 604.4 KB | ||
| 2024-12-20 08:00 |
Regulatory News Service
Inside Information / Other news releases
|
English | 296.9 KB | ||
| 2024-12-20 08:00 |
M&A Activity
Informations privilégiées / Autres communiqués
|
French | 284.3 KB | ||
| 2024-10-22 18:00 |
Regulatory News Service
Inside Information / Other news releases
|
English | 310.0 KB | ||
| 2024-10-22 18:00 |
Regulatory News Service
Informations privilégiées / Autres communiqués
|
French | 312.5 KB |
Automate Your Workflow. Get a real-time feed of all Oncodesign Precision Medicine S.A filings delivered via API.
Market Data
Market Data Not Available
Financials & KPIs
No Financial Data Available
Standardized financial statements for the selected period are not yet available.
Need More History? Access decades of standardized financials for Oncodesign Precision Medicine S.A via our API.
Insider Transactions
| Date | Insider Name | Position | Type | Shares | Value |
|---|---|---|---|---|---|
| No insider transactions recorded for this company. | |||||
